97 related articles for article (PubMed ID: 18634198)
1. Protein-protein interactions as new drug targets. Preface.
Klussmann E; Rosenthal W
Handb Exp Pharmacol; 2008; (186):v-vi. PubMed ID: 18634198
[No Abstract] [Full Text] [Related]
2. Disruption of protein-protein interactions: towards new targets for chemotherapy.
Loregian A; Palù G
J Cell Physiol; 2005 Sep; 204(3):750-62. PubMed ID: 15880642
[TBL] [Abstract][Full Text] [Related]
3. Predicting druggable binding sites at the protein-protein interface.
Fuller JC; Burgoyne NJ; Jackson RM
Drug Discov Today; 2009 Feb; 14(3-4):155-61. PubMed ID: 19041415
[TBL] [Abstract][Full Text] [Related]
4. Drug-binding cavities in long-lived biologics: cause for concern but also potential benefit.
Panayotatos N
J Clin Pharmacol; 2008 Oct; 48(10):1208-11. PubMed ID: 18812610
[TBL] [Abstract][Full Text] [Related]
5. iPEP: peptides designed and selected for interfering with protein interaction and function.
Mason JM; M Müller K; Arndt KM
Biochem Soc Trans; 2008 Dec; 36(Pt 6):1442-7. PubMed ID: 19021572
[TBL] [Abstract][Full Text] [Related]
6. Discovering and improving novel peptide therapeutics.
McGregor DP
Curr Opin Pharmacol; 2008 Oct; 8(5):616-9. PubMed ID: 18602024
[TBL] [Abstract][Full Text] [Related]
7. Modulating receptor function through RAMPs: can they represent drug targets in themselves?
Sexton PM; Poyner DR; Simms J; Christopoulos A; Hay DL
Drug Discov Today; 2009 Apr; 14(7-8):413-9. PubMed ID: 19150656
[TBL] [Abstract][Full Text] [Related]
8. Peptidic modulators of protein-protein interactions: progress and challenges in computational design.
Rubinstein M; Niv MY
Biopolymers; 2009 Jul; 91(7):505-13. PubMed ID: 19226619
[TBL] [Abstract][Full Text] [Related]
9. In search of negative allosteric modulators of biological targets.
Groebe DR
Drug Discov Today; 2009 Jan; 14(1-2):41-9. PubMed ID: 18973826
[TBL] [Abstract][Full Text] [Related]
10. Contribution of structural biology to clinically validated target proteins.
Mori M; Ogawa N; Tanikawa K; Dodo S; Shibayama S; Yokoyama S; Tanaka A
Drug Discov Today; 2008 Jun; 13(11-12):469-72. PubMed ID: 18549971
[TBL] [Abstract][Full Text] [Related]
11. The analysis of the drug-targets based on the topological properties in the human protein-protein interaction network.
Zhu M; Gao L; Li X; Liu Z; Xu C; Yan Y; Walker E; Jiang W; Su B; Chen X; Lin H
J Drug Target; 2009 Aug; 17(7):524-32. PubMed ID: 19530902
[TBL] [Abstract][Full Text] [Related]
12. Peptides as protein binding site mimetics.
Eichler J
Curr Opin Chem Biol; 2008 Dec; 12(6):707-13. PubMed ID: 18935974
[TBL] [Abstract][Full Text] [Related]
13. Seeing small molecules in action with bioorthogonal chemistry.
Raghavan AS; Hang HC
Drug Discov Today; 2009 Feb; 14(3-4):178-84. PubMed ID: 18973827
[TBL] [Abstract][Full Text] [Related]
14. Delivery of peptide and protein drugs over the blood-brain barrier.
Brasnjevic I; Steinbusch HW; Schmitz C; Martinez-Martinez P;
Prog Neurobiol; 2009 Apr; 87(4):212-51. PubMed ID: 19395337
[TBL] [Abstract][Full Text] [Related]
15. Druggable targets and targeted drugs: enhancing the development of new therapeutics.
Billingsley ML
Pharmacology; 2008; 82(4):239-44. PubMed ID: 18802381
[TBL] [Abstract][Full Text] [Related]
16. The design of polyvalent therapeutics.
Joshi A; Vance D; Rai P; Thiyagarajan A; Kane RS
Chemistry; 2008; 14(26):7738-47. PubMed ID: 18553325
[TBL] [Abstract][Full Text] [Related]
17. Structure-based design of molecular cancer therapeutics.
van Montfort RL; Workman P
Trends Biotechnol; 2009 May; 27(5):315-28. PubMed ID: 19339067
[TBL] [Abstract][Full Text] [Related]
18. Protein-based nanomedicine platforms for drug delivery.
Maham A; Tang Z; Wu H; Wang J; Lin Y
Small; 2009 Aug; 5(15):1706-21. PubMed ID: 19572330
[TBL] [Abstract][Full Text] [Related]
19. Conciliating binding efficiency and polypharmacology.
Mestres J; Gregori-Puigjané E
Trends Pharmacol Sci; 2009 Sep; 30(9):470-4. PubMed ID: 19717193
[TBL] [Abstract][Full Text] [Related]
20. RNA interference screening for the discovery of oncology targets.
Quon K; Kassner PD
Expert Opin Ther Targets; 2009 Sep; 13(9):1027-35. PubMed ID: 19650760
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
